USP17L2 and cancer: Moreover, since DUB3 is a veritable oncogene due to its ability to stabilize Snail, Geminin, Cdc25A, NRF2, BRD4, and Cyclin A87–93, targeting DUB3 may be a promising strategy in cancer treatment with potentially fewer side effects.